Communication With Mechanically Ventilated Intensive Care Patients
Launched by OSLO UNIVERSITY HOSPITAL · May 14, 2025
Trial Information
Current as of August 19, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The specific objectives of the research proposal are to:
1. Investigate ICU patients' perceptions of communication difficulties during mechanical ventilation, and evaluate the relationship between communication difficulties and symptom burden.
2. Describe ICU nurses' communication skills, communication techniques commonly used, and satisfaction with communication with patients.
The results from objectives 1 and 2 are of relevance as such, but will also be used as a basis to develop the COMMEC-ICU and as a pre-intervention measure prior to implementation of the new program.
3. Further d...
Gender
ALL
Eligibility criteria
- Inclusion Criteria patients:
- • Patients over the age of 18
- • First ICU admission during the hospital stay
- • Cognitively competent at the time of consenting to participate
- • Invasive mechanical ventilation via endotracheal tube or tracheostomy for over 48 hours or more calendar days
- • Patients must have been reported awake and communicative or with a Richmond Agitation and Sedation scale over - 1.
- Exclusion Criteria patients:
- • Patients who cannot understand Norwegian
- • Patients without an address
- • Patients who have cognitive disabilities and are not able to consent or receive information about the study
- • Inclusion criteria nurses: having clinical experience from the ICU for more than a year.
About Oslo University Hospital
Oslo University Hospital is a leading academic medical center in Norway, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital integrates cutting-edge scientific inquiry with patient care, fostering an environment that promotes the development of new therapies and treatment strategies. With a multidisciplinary approach, Oslo University Hospital collaborates with various stakeholders, including researchers, healthcare professionals, and industry partners, to enhance clinical outcomes and contribute to the global medical community. Its dedication to ethical standards and patient safety ensures that all trials are conducted with the highest level of integrity and respect for participant welfare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oslo, , Norway
Patients applied
Trial Officials
Tone Rustøen, PhD
Principal Investigator
OUS
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported